Skip to main content

Peer Review reports

From: Concomitant use of pembrolizumab and entinostat in adult patients with metastatic uveal melanoma (PEMDAC study): protocol for a multicenter phase II open label study

Original Submission
19 Nov 2018 Submitted Original manuscript
10 Jan 2019 Reviewed Reviewer Report - ANTHONY Brent DANIELS
30 Jan 2019 Reviewed Reviewer Report - Joe Sacco
11 Feb 2019 Reviewed Reviewer Report - Richard Carvajal
14 Mar 2019 Author responded Author comments - Henrik Jespersen
Resubmission - Version 2
14 Mar 2019 Submitted Manuscript version 2
4 Apr 2019 Reviewed Reviewer Report - Richard Carvajal
15 Apr 2019 Author responded Author comments - Henrik Jespersen
Resubmission - Version 3
15 Apr 2019 Submitted Manuscript version 3
Publishing
18 Apr 2019 Editorially accepted
2 May 2019 Article published 10.1186/s12885-019-5623-3

You can find further information about peer review here.

Back to article page